OrbiMed's Oncology Portfolio

XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

Erasca is a developer of oncology drugs intended to provide precision oncology options.

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.